Congratulations to Dr. Martin Safo
Dr. Martin Safo, named PI on an R61 grant from NIH, “Targeted Identification of Dual Acting Antisickling Agents for Sickle Cell Disease Therapy,” totaling $575,593.
Dr. Martin Safo, named PI on an R61 grant from NIH, “Targeted Identification of Dual Acting Antisickling Agents for Sickle Cell Disease Therapy,” totaling $575,593.